Advertisement

GI & Endoscopy

Device company EndoChoice is planning a $100 million to $150 million NASDAQ initial public offering for 2015, according to a Jewish Business News report.

Advertisement

What is the future of gastroenterology and endoscopy in ASCs? Whatever ends up coming to pass, the best way GI physicians can ensure practice success is through remaining aware of potential challenges that riddle the current healthcare landscape, according to…

United States drug manufacturer AbbVie conducted a survey that assessed whether or not gastroenterologists underestimate the severity of Crohn's disease and ulcerative colitis, according to a report by thepharmaletter.

Advertisement